Pfizer Inc. (PFE) Stock

Pfizer Inc. operates as a leading global biopharmaceutical company, specializing in the discovery, development, manufacturing, marketing, distribution, and sale of a wide array of medicines and vaccines. Its diverse portfolio encompasses therapeutic areas such as cardiovascular metabolic health, women's health, oncology, immunology, and infectious diseases. The company markets well-known brands like Eliquis for cardiovascular care, Ibrance for breast cancer treatment, and vaccines such as Comirnaty for COVID-19 prevention, leveraging its expertise in biologics, small molecules, immunotherapies, and biosimilars.

Furthermore, Pfizer is actively involved in sterile injectables, anti-infectives, and oral COVID-19 treatments, contributing to global health efforts. It also focuses on addressing chronic immune and inflammatory diseases with biosimilar treatments like Xeljanz and Enbrel. Beyond therapeutics, Pfizer engages in contract manufacturing, serving a broad spectrum of customers including wholesalers, retailers, hospitals, clinics, and government agencies worldwide.

Established in 1849 and headquartered in New York City, Pfizer continues to pioneer innovative healthcare solutions through strategic collaborations with prominent partners such as Bristol-Myers Squibb, BioNTech, and Merck KGaA. This collaborative approach enhances its research capabilities and reinforces its commitment to advancing medical science, improving patient outcomes, and addressing global health challenges with cutting-edge pharmaceutical innovations.